Toxicological evaluation of an ethanolic extract from Chiococca alba roots.
The roots of Chiococca alba have been employed to treat rheumatic disorders and for other therapeutic purposes in Brazil and elsewhere. This study was undertaken to evaluate the toxicological properties of an ethanolic extract from Chiococca alba roots (EE), including mutagenicity in the Salmonella assay and acute and subacute toxicity to mice. Single oral doses of EE caused hypoactivity, but no deaths were noted up to the highest dose tested (2000 mg/kg). EE (500 mg/kg p.o.) reduced mouse locomotion in the open field test. EE was markedly more toxic when given by intraperitoneal (i.p.) and subcutaneous (s.c.) routes. Acute approximate lethal doses (ALD) were 125 mg/kg (males) and 250 mg/kg (females) and 250 mg/kg (both sexes) by i.p. and s.c. routes, respectively. Deaths after single doses were preceded by hypoactivity, ataxia and lethargy. Repeated administration of EE by gavage for 14 days caused no deaths. Activity of liver monooxygenases (pentoxy- and ethoxyresorufin-O-dealkylases) was not altered by repeated treatment with EE (2000 mg/kg/day p.o.). Administration of EE by the i.p. route for 14 days decreased weight gain and caused anemia, neutrophilia and deaths. The no-observed-adverse-effect level (NOAEL) for subacute treatment by the i.p. route was as low as 15.6 mg of EE/kg body weight (wt)/day. EE was not mutagenic in the Salmonella/microsome assay with TA100, TA98, TA97a and TA1535 strains. In summary, EE was not mutagenic and presented a low acute and subacute toxicity by the oral route. Toxicities by parenteral routes, however, were more pronounced.